Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation

  • Bastidas-Mora, Gabriela
  • Bea, Sílvia|||0000-0001-7192-2385
  • Navarro, Alba|||0000-0002-4041-0974
  • Giné, Eva|||0000-0002-0532-1204
  • Costa, Dolors|||0000-0002-8276-3292
  • Delgado, Julio|||0000-0002-5157-4376
  • Baumann, Tycho|||0000-0003-4421-0088
  • Magnano, Laura|||0000-0002-6928-8386
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Villamor, Neus|||0000-0001-6538-4111
  • Colomer, Dolors|||0000-0001-7486-8484
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Rozman, Maria|||0000-0002-2641-1110
  • Balagué, Olga|||0000-0002-5099-3675
  • Martínez Hernández, Daniel|||0000-0001-7492-5311
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Blanes, Margarita
  • Climent, Fina|||0000-0002-4360-8388
  • Campo, Elias|||0000-0001-9850-9793
  • Wotherspoon, Andrew
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Matutes, Estella|||0000-0001-6745-7046
We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation (SMZL-T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital Clinic of Barcelona (HCB) and 21 diagnosed with SMZL-T in other centres. In the HCB cohort, the cumulative incidence of transformation at 5 years was 15%. Predictors for transformation were cytopenias, hypoalbuminaemia, complex karyotype (CK) and both the Intergruppo Italiano Linfomi (ILL) and simplified Haemoglobin, Platelet count, lactate dehydrogenase (LDH) and extrahilar Lymphadenopathy (HPLL)/ABC scores (P < 0·05). The only independent predictor for transformation in multivariate analysis was CK [hazard ratio (HR) 4·025, P = 0·05]. Patients with SMZL-T had a significantly higher risk of death than the remainder (HR 3·89, P < 0·001). Of the 36 patients with SMZL-T, one developed Hodgkin lymphoma and 35 a diffuse large B-cell lymphoma, 71% with a non-germinal centre phenotype. The main features were B symptoms, lymphadenopathy, and high serum LDH. CK was observed in 12/22 (55%) SMZL-T and fluorescence in situ hybridisation detected abnormalities of MYC proto-oncogene, basic helix-loop-helix transcription factor (MYC), B-cell leukaemia/lymphoma 2 (BCL2) and/or BCL6 in six of 14 (43%). In all, 21 patients received immunochemotherapy, six chemotherapy, one radiotherapy and three splenectomy. The complete response (CR) rate was 61% and the median survival from transformation was 4·92 years. Predictors for a worse survival in multivariate analysis were high-risk International Prognostic Index (HR 5·294, P = 0·016) and lack of CR (HR 2·67, P < 0·001).